FloSpine clinches $1.7M in seed funding


Spine devicemaker FloSpine has secured $1.7 million in seed funding after recently closing on $530,000 in capital, according to a July 8 report from Refresh Miami.

Investors in the company include business people, physicians and a Silicon Valley firm, according to the report. 

FloSpine's main product focus is KeyLift, a product that relieves compression from spinal stenosis. It is the first expandable interlaminar stabilization procedure for the condition on the market, according to the devicemaker. 

FloSpine was founded in 2011 and is headquartered at Florida Atlantic University. It has a team of 12. The company holds eight patents for devices geared toward the spine, including the KeyLift.

The KeyLift was developed alongside Oklahoma City-based surgeon Cheng-Lun Soo, MD, who had been using FloSpine products for several years, according to the report. The device received FDA clearance last fall and already has been used in several procedures.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.